This highlights the importance of planning for back-up therapies (ie, administration of PTH subcutaneous injections or oral calcium and active vitamin D or having a new pod and medication available) to prevent hypocalcemia in case of pod failure. This evidence concerns the gene PTH and Hypocalcemia.